Market Closed -
Japan Exchange
02:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
1,038
JPY
|
0.00%
|
|
+2.98%
|
-26.80%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,157
|
4,638
|
10,213
|
6,785
|
4,618
|
-
|
-
|
Enterprise Value (EV)
1 |
5,385
|
8,645
|
15,296
|
11,880
|
4,618
|
4,618
|
4,618
|
P/E ratio
|
27.1
x
|
81.5
x
|
25
x
|
74
x
|
27
x
|
18.4
x
|
14.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.41
x
|
0.51
x
|
0.88
x
|
0.5
x
|
0.28
x
|
0.24
x
|
0.21
x
|
EV / Revenue
|
0.41
x
|
0.51
x
|
0.88
x
|
0.5
x
|
0.28
x
|
0.24
x
|
0.21
x
|
EV / EBITDA
|
5,832,169
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-20,989,176
x
|
-2,995,868
x
|
-26,805,986
x
|
-8,799,992
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
2.95
x
|
4.11
x
|
7.51
x
|
4.68
x
|
2.87
x
|
2.48
x
|
2.13
x
|
Nbr of stocks (in thousands)
|
4,488
|
4,488
|
4,489
|
4,449
|
4,449
|
-
|
-
|
Reference price
2 |
703.3
|
1,033
|
2,275
|
1,525
|
1,038
|
1,038
|
1,038
|
Announcement Date
|
20-05-15
|
21-05-14
|
22-05-13
|
23-05-15
|
-
|
-
|
-
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,730
|
9,132
|
11,625
|
13,694
|
16,636
|
19,401
|
22,043
|
EBITDA
|
541.2
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
328
|
219
|
491
|
-234
|
235
|
365
|
454
|
Operating Margin
|
4.24%
|
2.4%
|
4.22%
|
-1.71%
|
1.41%
|
1.88%
|
2.06%
|
Earnings before Tax (EBT)
|
158
|
131
|
604
|
218
|
-
|
-
|
-
|
Net income
1 |
104
|
56
|
407
|
91
|
173
|
254
|
313
|
Net margin
|
1.35%
|
0.61%
|
3.5%
|
0.66%
|
1.04%
|
1.31%
|
1.42%
|
EPS
2 |
25.91
|
12.68
|
90.93
|
20.62
|
38.50
|
56.50
|
69.70
|
Free Cash Flow
|
-150.4
|
-1,548
|
-381
|
-771
|
-
|
-
|
-
|
FCF margin
|
-1.95%
|
-16.95%
|
-3.28%
|
-5.63%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-05-15
|
21-05-14
|
22-05-13
|
23-05-15
|
-
|
-
|
-
|
Fiscal Period: March |
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
4,277
|
5,321
|
3,110
|
3,338
|
6,715
|
3,482
|
3,959
|
8,111
|
4,182
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-12
|
246
|
163
|
116
|
179
|
-2
|
24
|
30
|
-96
|
Operating Margin
|
-0.28%
|
4.62%
|
5.24%
|
3.48%
|
2.67%
|
-0.06%
|
0.61%
|
0.37%
|
-2.3%
|
Earnings before Tax (EBT)
1 |
-104
|
471
|
98
|
118
|
125
|
-36
|
94
|
133
|
-10
|
Net income
1 |
-133
|
290
|
53
|
72
|
83
|
-40
|
51
|
79
|
5
|
Net margin
|
-3.11%
|
5.45%
|
1.7%
|
2.16%
|
1.24%
|
-1.15%
|
1.29%
|
0.97%
|
0.12%
|
EPS
2 |
-29.68
|
64.62
|
11.77
|
16.32
|
18.86
|
-9.050
|
11.67
|
17.81
|
1.220
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-11-13
|
21-11-12
|
22-02-14
|
22-08-12
|
22-11-14
|
23-02-14
|
23-08-14
|
23-11-14
|
24-02-14
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
2,228
|
4,007
|
5,083
|
5,095
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.117
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-150
|
-1,548
|
-381
|
-771
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
14.2%
|
5.2%
|
33%
|
6.6%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
3.06%
|
5.91%
|
0.31%
|
-
|
-
|
-
|
Assets
1 |
-
|
1,832
|
6,881
|
28,949
|
-
|
-
|
-
|
Book Value Per Share
2 |
239.0
|
251.0
|
303.0
|
326.0
|
361.0
|
418.0
|
488.0
|
Cash Flow per Share
|
73.70
|
58.80
|
145.0
|
70.60
|
-
|
-
|
-
|
Capex
|
1,339
|
1,803
|
824
|
863
|
-
|
-
|
-
|
Capex / Sales
|
17.33%
|
19.74%
|
7.09%
|
6.3%
|
-
|
-
|
-
|
Announcement Date
|
20-05-15
|
21-05-14
|
22-05-13
|
23-05-15
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -26.80% | 29.68M | | +18.92% | 81.04B | | -29.48% | 68.93B | | +9.65% | 29.59B | | -0.14% | 17.24B | | -9.30% | 16.99B | | +0.20% | 15.12B | | +5.25% | 13.09B | | +68.96% | 12B | | -2.88% | 11.94B |
Other Healthcare Facilities & Services
|